North America Continuous Glucose Monitoring Devices Market Size & Outlook
North America continuous glucose monitoring devices market, 2018-2030 (US$M)
Related Markets
North America continuous glucose monitoring devices market highlights
- The North America continuous glucose monitoring devices market generated a revenue of USD 1,565.8 million in 2022.
- The market is expected to grow at a CAGR of 8.4% from 2023 to 2030.
- In terms of segment, transmitter & receiver was the largest revenue generating product in 2022.
- Insulin Pumps is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, U.S. is expected to register the highest CAGR from 2023 to 2030.
North America data book summary
| Market revenue in 2022 | USD 1,565.8 million |
| Market revenue in 2030 | USD 2,981.2 million |
| Growth rate | 8.4% (CAGR from 2022 to 2030) |
| Largest segment | Transmitter & receiver |
| Fastest growing segment | Insulin Pumps |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Sensors, Transmitter & Receiver, Insulin Pumps |
| Key market players worldwide | DexCom Inc, Abbott Laboratories, Medtronic PLC, Ypsomed Holding AG, Senseonics Holdings Inc, A.Menarini Diagnostics, Signos |
Other key industry trends
- In terms of revenue, North America region accounted for 37.4% of the global continuous glucose monitoring devices market in 2022.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,883.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Continuous Glucose Monitoring Devices Market Scope
Continuous Glucose Monitoring Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America continuous glucose monitoring devices market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to continuous glucose monitoring devices market will help companies and investors design strategic landscapes.
Transmitter & receiver was the largest segment with a revenue share of 36.9% in 2022. Horizon Databook has segmented the North America continuous glucose monitoring devices market based on sensors, transmitter & receiver, insulin pumps covering the revenue growth of each sub-segment from 2018 to 2030.
In 2023, North America dominated the Continuous Glucose Monitoring (CGM) devices market, accounting for the largest share of 38.66% and is expected to maintain its dominance during the forecast period.
Some of the key players, such as Abbott, Medtronic, and Dexcom, have their operational headquarters in North America, which is contributing to the market growth. Furthermore, the adoption of smart CGM devices and technologically advanced devices, such as the use of Artificial Intelligence (AI) & data analytics, are driving market growth.
Reasons to subscribe to North America continuous glucose monitoring devices market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America continuous glucose monitoring devices market databook
-
Our clientele includes a mix of continuous glucose monitoring devices market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America continuous glucose monitoring devices market , including forecasts for subscribers. This continent databook contains high-level insights into North America continuous glucose monitoring devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America continuous glucose monitoring devices market size, by country, 2018-2030 (US$M)
North America Continuous Glucose Monitoring Devices Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
